# Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis

> **NCT01992029** · — · TERMINATED · sponsor: **University Hospital, Bordeaux** · enrollment: 5 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- ALS

## Interventions

- **OTHER:** Clinical evaluation
- **PROCEDURE:** Muscular biopsy
- **PROCEDURE:** Lumbar puncture
- **PROCEDURE:** Blood sampling
- **OTHER:** Neurological assessments
- **PROCEDURE:** Neuro-muscular biopsy and lumbar puncture
- **PROCEDURE:** Muscular biopsy
- **PROCEDURE:** Blood sample
- **DEVICE:** Cervical spinal cord and brain MRI

## Key facts

- **NCT ID:** NCT01992029
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06-17
- **Primary completion:** 2015-10
- **Final completion:** 2015-10-22
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992029, "Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01992029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*